Community Center

Pfizer is a leading research-based biopharmaceutical company. We apply science and our global resources to deliver innovative therapies that extend and…

Documenting my dad's journey with AL Amyloidosis. "When oceans rise, my soul will rest in Your embrace. For I am Yours and You are mine!"

Hematologist and Oncologist, Director, Amyloidosis Center @amyloidosis_bu. Hematologist and Oncologist @The_BMC

Supporting patients and families while promoting research, education and awareness.

Cardiologist at Mayo Clinic. Former junior #Musketeer. #amyloidosis and #echo. Tweets limited to medicine and #Xavier basketball. My own and not my employer's.

Eidos Therapeutics, a subsidiary of BridgeBio Pharma, is developing AG10 as a targeted therapeutic for transthyretin amyloidosis. The company's singular mission is…

Dr. Suzanne Lentzsch, MD, PhD. Director of the Multiple Myeloma and Amyloidosis Service at Columbia University Medical Center.

Nephros is a commercial stage medical device company that develops and sells high-performance liquid purification filters. Nephros filters capture contaminants as…

Stanford IM residency program director, Cardiologist, Specialist in Amyloidosis, Cardio-Oncology, and Advanced heart failure.

BSIM's mission is to deliver quality drug candidates with high capital efficiency against transthyretin-mediated amyloidosis, including clinical manifestations and…